KATHRYN TLOCZYNSKI: Open Payments
NPI 1356537328 · DUBLIN, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$565 in 25 payments from 11 companies in 2025. Trend: 2023 $304 · 2024 $629 · 2025 $565
Food & beverage: $565
| Company | Payments | Amount |
|---|---|---|
| GENZYME CORPORATION | 3 | $99 |
| ABBVIE INC. | 5 | $85 |
| Janssen Biotech, Inc. | 4 | $84 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 3 | $76 |
| Almirall LLC | 2 | $51 |
| PFIZER INC. | 3 | $50 |
| Novartis Pharmaceuticals Corporation | 1 | $31 |
| LEO Pharma Inc. | 1 | $31 |
| Arcutis Biotherapeutics, Inc. | 1 | $22 |
| E.R. Squibb & Sons, L.L.C. | 1 | $20 |
Products named: DUPIXENT, SKYRIZI, TREMFYA, ILUMYA, Seysara, CIBINQO, Rhapsido, ANZUPGO.
Industry payments across OH — which companies pay providers there.
